Order Article Reprints

Zhu Q, Wang J, Yu H, Hu Q, Bateman NW, Long M, Rosario S, Schultz E, Dalgard CL, Wilkerson MD, et al. Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers. Cancers. 2022; 14(10):2350. https://doi.org/10.3390/cancers14102350

Zhu, Qianqian, Jie Wang, Han Yu, Qiang Hu, Nicholas W. Bateman, Mark Long, Spencer Rosario, Emily Schultz, Clifton L. Dalgard, Matthew D. Wilkerson, and et al. 2022. "Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers" Cancers 14, no. 10: 2350. https://doi.org/10.3390/cancers14102350

Zhu, Q., Wang, J., Yu, H., Hu, Q., Bateman, N. W., Long, M., Rosario, S., Schultz, E., Dalgard, C. L., Wilkerson, M. D., Sukumar, G., Huang, R.-Y., Kaur, J., Lele, S. B., Zsiros, E., Villella, J., Lugade, A., Moysich, K., Conrads, T. P., ... Odunsi, K. (2022). Whole-Genome Sequencing Identifies PPARGC1A as a Putative Modifier of Cancer Risk in BRCA1/2 Mutation Carriers. Cancers, 14(10), 2350. https://doi.org/10.3390/cancers14102350